Wang Xue, Xuan Lili, Pan Ying
Department of Obstetrics & Gynecology, China-Japan Union Hospital of Jilin University, Changchun, People's Republic of China.
Beilstein J Nanotechnol. 2022 Feb 22;13:255-264. doi: 10.3762/bjnano.13.20. eCollection 2022.
Melanoma is one of the deadliest forms of cancer, for which therapeutic regimens are usually limited by the development of resistance. Here, we fabricated FeO nanoparticle clusters (NPCs), which have drawn widespread attention, and investigated their role in the treatment of melanoma by photothermal therapy (PTT). Scanning electron microscopy imaging shows that our synthesized NPCs are spherical with an average diameter of 329.2 nm. They are highly absorptive at the near-infrared wavelength of 808 nm and efficient at locally converting light into heat. In vitro experiments using light-field microscopy and cell viability assay showed that FeO NPCs, in conjunction with near-infrared irradiation, effectively ablated A375 melanoma cells by inducing overt apoptosis. Consistently, in vivo studies using BALB/c mice found that intratumoral administration of FeO NPCs and concomitant in situ exposure to near-infrared light significantly inhibited the growth of implanted tumor xenografts. Finally, we revealed, by experimental approaches including semi-quantitative PCR, western blot and immunohistochemistry, the heat shock protein HSP70 to be upregulated in response to PTT, suggesting this chaperone protein could be a plausible underlying mechanism for the observed therapeutic outcome. Altogether, our results highlight the promise of FeO NPCs as a new PTT option to treat melanoma.
黑色素瘤是最致命的癌症形式之一,其治疗方案通常受到耐药性发展的限制。在此,我们制备了备受广泛关注的FeO纳米颗粒簇(NPCs),并研究了它们在通过光热疗法(PTT)治疗黑色素瘤中的作用。扫描电子显微镜成像显示,我们合成的NPCs呈球形,平均直径为329.2 nm。它们在808 nm的近红外波长下具有高吸收性,并且能有效地将光局部转化为热。使用光场显微镜和细胞活力测定的体外实验表明,FeO NPCs与近红外照射相结合,通过诱导明显的凋亡有效地消融了A375黑色素瘤细胞。同样,使用BALB/c小鼠的体内研究发现,瘤内注射FeO NPCs并同时原位暴露于近红外光可显著抑制植入的肿瘤异种移植物的生长。最后,我们通过包括半定量PCR、蛋白质印迹和免疫组织化学在内的实验方法揭示,热休克蛋白HSP70在PTT作用下上调,表明这种伴侣蛋白可能是观察到的治疗效果的一个合理潜在机制。总之,我们的结果突出了FeO NPCs作为治疗黑色素瘤的一种新的PTT选择的前景。